Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 05/27/16

    • 30-Day SEC Yield1

      1.41%
    • Total Net Assets

      $257.8M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      06/30/2016
  • Portfolio Composition (%)
    as of 05/27/16

    • % of Net Assets
    • Stocks

      99.87
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.13
  • Download All HoldingsDaily Holdings (%) as of 05/27/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Pfizer Inc
    PFE US
    435,717
    15,080,1655.85
    Abbvie Inc
    ABBV US
    229,794
    14,410,3825.59
    Novartis Ag
    NVS US
    178,929
    14,334,0025.56
    Bristol-Myers Squibb Co
    BMY US
    197,714
    14,098,9855.47
    Merck & Co Inc
    MRK US
    247,483
    13,977,8405.42
    Glaxosmithkline Plc
    GSK US
    324,115
    13,855,9165.38
    Johnson & Johnson
    JNJ US
    121,291
    13,713,1605.32
    Shire Plc
    SHPG US
    73,313
    13,706,5985.32
    Sanofi
    SNY US
    322,021
    13,286,5865.15
    Mckesson Corp
    MCK US
    72,042
    13,055,4515.06
    Novo Nordisk A/S
    NVO US
    232,891
    12,911,4775.01
    Astrazeneca Plc
    AZN US
    398,305
    11,901,3534.62
    Eli Lilly & Co
    LLY US
    158,585
    11,892,2894.61
    Zoetis Inc
    ZTS US
    251,906
    11,884,9254.61
    Abbott Laboratories
    ABT US
    296,907
    11,668,4454.53
    Allergan Plc
    AGN US
    44,687
    10,543,4514.09
    Teva Pharmaceutical Industries Ltd
    TEVA US
    201,422
    10,405,4614.04
    Mylan Nv
    MYL US
    192,688
    8,297,1453.22
    Amerisourcebergen Corp
    ABC US
    102,805
    7,610,6542.95
    Perrigo Co Plc
    PRGO US
    78,000
    7,535,5802.92
    Valeant Pharmaceuticals International I
    VRX US
    174,434
    4,957,4141.92
    Jazz Pharmaceuticals Plc
    JAZZ US
    21,700
    3,300,3531.28
    Mallinckrodt Plc
    MNK US
    43,239
    2,716,7061.05
    Akorn Inc
    AKRX US
    38,241
    1,153,3490.45
    Endo International Plc
    ENDP US
    74,589
    1,147,1790.45
    Other/Cash
    --
    --
    333,6850.13
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.